INS and Hyperglycemia: Intriguingly, the carboplatin/5-FU rats in the Drug group exhibited a decrease in blood glucose levels, a finding that diverges from the anticipated chemotherapy-associated hyperglycemia often attributed to impaired insulin production (Guo et al. 2018).